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Prevalence of β-hemolytic Streptococcus in children with special 
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Pharyngotonsillitis by β-hemolytic Streptococcus mostly affects children and imunocompromissed, 
being Streptococcus pyogenes (Group A) the most common agent in bacterial pharyngotonsillitis.
Aim: This work targeted the research of β-hemolytic Streptococcus Group-A (SBHGA) and No-A 
(SBHGNA) in the oropharynx of individuals with special health needs from the APAE (Maceió-AL).
Method: A prospective study with oropharynx samples from patients with Down syndrome and other 
mental disorders (test) and students from a private school (control) aged 5-15 years. Cultures in blood 
agar (5%) were identified through Gram/catalase tests and bacitracin/trimethoprim-sulfamethoxazole 
disk diffusion method, applying the chi-squared statistical analysis.
Results: A total of 222 bacterial colonies were isolated in 74 individuals from APAE and 65 in the 
control group. In the test group, previous episodes of pharyngotonsillitis were reported by 36.49% 
(27/74) and 9.46% (7/74) were diagnosed with symptoms and/or signs suggestive of oropharynx 
infection. No positive sample of S. pyogenes was confirmed at APAE, being all samples classified as 
SBHGNA, with 5 SBHGA in the control group.
Conclusion: The early identification of β-hemolytic Streptococcus is important for the fast treatment 
of pharyngotonsillitis and the absence of S. pyogenes avoid future suppurative or not-suppurative 
sequels in the group from APAE.
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INTRODUCTION
Pharyngotonsillitis by Streptococcus affects 
more frequently pediatric patients aged ranging 
between three and 16 years1. Children frequen-
ting day care centers may have incidence rates 
of respiratory tract infections up to 18 times 
greater than individuals of the same age who do 
not go to crowded enclosed spaces, and require 
antimicrobial drug therapy after complementary 
diagnosis2. However, individuals of all ages are 
susceptible to the propagation of this microorga-
nism in conditions of overcrowding, as its inter-
personal dissemination occurs through sputter or 
by direct contact, mainly in environments where 
large crowds get together, such as schools and 
day care centers3. Although bacterial infection 
accounts for only 10% of the cases of pharyn-
gotonsillitis, this disease remains as a significant 
public health problem, as it may affect a large 
number of children and dissemination occurs 
easily among patients, students, and immuno-
compromised individuals in closed spaces4,5.
The main etiological agent of bacterial 
pharyngotonsillitis is group A Streptococcus 
(Streptococcus pyogenes; or GAS). It is related 
to a wide range of diseases, including impetigo, 
urinary tract infections, septic arthritis, peritoni-
tis, and toxic shock syndrome. More specifically, 
this bacterium is generally associated with upper 
respiratory tract infections such as tonsillitis 
and pharyngitis, and also causes bronchitis. In 
addition to that, undiagnosed untreated episodes 
may lead to suppurative and non-suppurative 
sequelae such as glomerulonephritis and rheu-
matic fever respectively6,7.
The epidemiological observation of this 
pathogen is relevant due to the existence of 
complications and ease of transmission. Infec-
tions need to be managed more adequately and 
sequelae prevented by offering proper treat-
ment to patients suspected for and diagnosed 
with infection8. Quick detection methods are of 
paramount importance in isolating β-hemolytic 
Streptococcus, both GAS and non-GAS in suspec-
ted cases, thus avoiding the injudicious use of 
antimicrobial drugs and the onset of sequelae, 
mainly in immunocompromised individuals such 
as subjects with genetic syndromes with associa-
ted comorbidities.
This study looked into the prevalence rates 
of β-hemolytic Streptococcus and the presence 
of S. pyogenesin the oropharynx of children and 
adolescents with special needs seen at APAE 
(Associação de Pais e Amigos dos Excepcionais) 
in Maceió, AL, Brazil, between October of 2008 
and June of 2009. The control group was made 
up of chidren and adolescents from a private 
school located in Maceió-AL.
METHOD
This study was approved by the Ethics 
Committee of our institution and given permit nº 
018326/2008-08 and nº 010947/2008-35. The pa-
rents or guardians of the individuals enrolled in 
the study signed an informed consent term. This 
prospective cross-sectional historical cohort stu-
dy included children and adolescents with Down 
syndrome and other mental disorders (congenital 
cerebral palsy and moderate to severe mental 
retardation with associated physical impairments) 
seen at APAE, Maceió-AL aged between 5 and 
15 years in the case group. The control group 
included students from a private school located 
in the same region and within the same age 
range. The subjects from both groups had simi-
lar confinement routines in the institutions they 
attended and spent part of the day in a room 
with other children and adolescents. Individuals 
under five or over 15 years of age, subjects who 
were not fasting, who had done oral hygiene on 
sampling day, or who had been taking antibiotics 
recently were not enrolled in the study (exclu-
sion criteria). General and clinical information 
was obtained through standard questionnaires. 
Subjects had their oral cavities examined before 
oral sampling to identify symptoms of infection 
such as throat inflammation, hypertrophied ton-
sils, purulent plaque, and other factors such as 
local pain, fever, nasal obstruction, coughing, 
and symptoms experienced previously.
Oropharyngeal secretion samples were 
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taken from 74 children in the case group and 
65 in the control group between October of 
2008 and June of 2009. The protocol proposed 
by Winn et al.9 was used in order to standardize 
the lab workup used to identify the presence of 
GAS. Each swabwas transported in saline solu-
tion (0.9% NaCl) and each sample inoculated into 
a sheep blood agar slide (5%). After 24h-48h of 
candle jar incubation at 35°C, colonies suggestive 
of β-hemolytic Streptococcus were collected and 
transferred to a brain and heart infusion (BHI, 
Difco). Gram staining and biochemical tests 
were then performed to find whether there was 
catalase activity. The bacitracin susceptibility test 
using the disk diffusion method is presumptive 
for identification based on GAS (S. pyogenes) sen-
sitivity to 0.04 U of bacitracin. This application 
was used together with the sulfamethoxazole-
-trimethopim susceptibility test in sheep blood 
agar (5%) with disks containing respectively 1.25 
µg and 23.75 µg. This method can differentiate 
between groups of strep, once other groups of 
streptococci are sensitive and resistant to GAS. 
The samples collected in the control group were 
submitted to the same procedures described abo-
ve, and a standard strain of S. pyogenes (ATCC 
19615) was used in all experiments. The results 
were assessed through descriptive statistics, and 
the chi square test (χ2) was used to analyze the 
possible associations between symptomatic and 
asymptomatic subjects and children of different 
age ranges with and without previous involve-
ment by pharyngotonsillitis. On all cases, p < 
0.05 (5%) was used as a reference to reject the 
null hypothesis (H0).
RESULTS
Thirty-six of the 74 subjects in the case 
group had Down syndrome (48.64%), while the 
remaining individuals had various other mental 
disorders. In this group, previous episodes of 
pharyngotonsillitis were reported by 36.49% 
(27/74) of the subjects and prevalence rates were 
higher among individuals aged 6. Additionally, 
9.46% (7/74) of the children were diagnosed with 
symptoms or signs suggestive of oropharynx 
infection such as hypertrophied tonsils, redness, 
throat pain, and painful swallowing. None of 
them had aspiration pneumonia.
Two hundred and twenty-two samples from 
74 case group subjects were analyzed, as colo-
nies were isolated in triplicate for each clinical 
sample collected and cultured. All samples in 
the case group were categorized as belonging to 
the Streptococcus genus, as they had β-hemolytic 
colonies after culture in 5% sheep blood agar 
and were Gram-positive and catalase-negative. 
Although sensitivity to bacitracin was confirmed 
in isolated β-hemolytic colonies, unexpected 
results were seen and sensitivity to sulfametho-
xazole-trimethopim was observed for all 222 
tested colonies.
Despite the clinical diagnosis of pharyngo-
tonsillitis assigned to 9.46% (7/74) of the sub-
jects, the presence of GAS was not confirmed in 
oropharyngeal secretion samples of case group 
individuals with active symptoms. Thus, only 
β-hemolytic Streptococcus was detected in the 
obtained test material. Species of Streptococcus 
sensitive to bacitracin and sulfamethoxazole-tri-
methoprim (BA-SXT) are categorized β-hemolytic 
in strep groups C, F or G and, despite the si-
milarities, they are categorized as non-group A 
β-hemolytic Streptococcus (non-GAS). Nonethe-
less, in the control group the prevalence rates of 
GAS and non-GAS were 7.7% (5/65) and 6.15% 
(4/65) respectively, with 60% of the asympto-
matic carriers reporting previous episodes of 
pharyngotonsillitis. Table 1 shows the subjective 
characteristics and the statistical prevalence rates 
in children and adolescents with special needs, 
focusing on symptomatic individuals and subjects 
with previous episodes of pharyngotonsillitis.
Statistical analysis of case group subjects 
aged between five and 10 years and individu-
als aged between 11 and 15 was performed 
initially to elicit the differences in the number 
of asymptomatic and symptomatic individuals. 
The null hypothesis (H0) stated that the num-
ber of asymptomatic and symptomatic subjects 
is not correlated to age, while the affirmative 
hypothesis (H1) stated that age is correlated to 
the number of symptomatic and asymptomatic 
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individuals. Statistical calculation indicated that 
χ2 was equal to 0.0828, thus smaller than p < 0.05 
and indicative that H0 is true with the result of 
asymptomatic and symptomatic subjects between 
42/4 (5-10 years of age) and 25/3 (11-15 years of 
age). Another comparison between subjects used 
18/28 (5-10 years of age) and 9/19 (11-15 years 
of age) with and without previous pharyngo-
tonsillitis respectively, indicating as H0 the lack 
of a correlation with age range and as H1 the 
existence of a correlation with age, confirming 
H0 as χ2 was equal to 0.3667 (p < 0.05).
The search for Streptococcus and S. pyoge-
nes in the oropharynx of children with special 
needs was particularly important, as only non-
-GAS was found. Early identification allows for 
quick treatment and prevention of future episo-
des of strep pharyngotonsillitis in general and 
more specifically cases caused by S. pyogenes, 
thus avoiding suppurative and non-suppurative 
sequelae.
DISCUSSION
The gold standard for the diagnosis of pha-
ryngitis and pharyngotonsillitis is the culture of 
oropharynx secretion in 5% sheep blood agar, 
with sensitivity greater than 90%3,9,10. Researchers 
have confirmed that susceptibility to bacitracin 
offers presumptive identification with accuracy 
above 95% for GAS and ranging between 83%-
97% for non-group A streptococci5,11,12. GAS (S. 
pyogenes) is the most common cause of bacte-
rial pharyngitis, but other streptococci such as 
group C and G β-hemolytic strep5 may also cause 
acute pharyngitis. Sensitivity to bacitracin is of 
10% among group C, F, and G Streptococci; the 
sulfamethoxazole-trimethoprim test is recom-
mended to differentiate GAS and non-GAS, as 
the latter group is sensitive to SXT4. Therefore, 
when oropharynx secretion culture is positive 
for non-GAS, the usual clinical indication is an-
timicrobial therapy for S. pyogenes.
The presumptive identification of S. pyo-
genes in oropharynx secretion culture may be 
reliable when based on sensitivity to bacitracin or 
a positive test for pyrrolidonilarilamidase(PYR)3. 
There are various biochemical and microbiologi-
cal tests available for GAS, but bacitracin sensiti-
vity is the most widely used technique because 
it is highly sensitive and inexpensive, albeit not 
very specific13,14. Tests with blood agar, Gram 
staining, and bacitracin have been used in early 
screening for S. pyogenes followed by antigen 
detection tests10.
Sitkiewicz & Hryniewicz15 have found that 
similarly to GAS, groups B (GBS), C (GCS), and 
G (GGS) streptococci may be carried by humans 
and can cause diseases with symptoms identical 
to classic pharyngitis, but are rarely involved 
in invasive pyogenic infection. For five years 
in Buenos Aires, Argentina, Villar et al.16 have 
looked into samples of pharyngeal secretion of 
children aged between six months and 18 years 
and adults, and found non-GAS in 5.8% and 
18.9% of the subjects in each respective group, 
to conclude that special care is to be given not 
only to S. pyogenes, but also to other strepto-
cocci as cases of invasive infection by non-GAS 
in immunocompromised individuals have been 
reported.
Molecular analysis is increasingly used to 
subtype the various groups of streptococci and 
assess their virulence. In a broad study done 
in India17, the authors sent 1,040 samples of 
patients with acute pharyngitis for molecular 
typing based on emm genotypes and superan-
Table 1. Characteristics of individuals with special needs and 
reported previous pharyngotonsillitis.
Age Patients (n/%) Symptoms (n/%) Previous pharyngotonsillitis (n/%)
5 9/12.16 0/0 2/2.7
6 8/10.81 1/1.35 6/8.11
7 6/8.12 0/0 2/2.70
8 7/9.46 0/0 1/1.35
9 6/8.12 1/1.35 2/2.70
10 10/13.51 2/2.70 5/6.76
11 9/12.16 2/2.70 3/4.05
12 6/8.12 0/0 3/4.05
13 4/5.41 0/0 1/1.35
14 2/2.70 0/0 1/1.35
15 7/9.46 1/1.35 1/1.35
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tigens. In the end they found 124 individuals 
with β-hemolytic strains, 59.7% with GCS, 25% 
with GGS, and 15.3% with GAS, stressing once 
again the epidemiological relevance of non-GAS 
in active infections, in this case verified through 
Multiplex PCR. In 2011, another molecular study 
on β-hemolytic GAS, GCS, and GGS isolated 63% 
of non-invasive strains typed as non-GAS18.
Subjects with Down syndrome account for 
the majority of the case group individuals enrol-
led in this study, and are more frequently affected 
by episodes of infection as a result of immune 
system anomalies and possibly clinical compli-
cations arising from the syndrome19. Case group 
individuals in this study were more susceptible 
to infection or colonization by non-GAS when 
compared to controls. Proper practice dictates 
that asymptomatic and symptomatic subjects 
with any bacterial infection be identified through 
adequate clinical examination and workup as re-
quired. Generation of more epidemiological data 
on the prevalence of pathogens in children with 
special needs is needed, as only a few studies 
have been carried out on this group of subjects 
in specialized institutions. Further research may 
improve the clinical care provided to these in-
dividuals.
CONCLUSION
Non-group A β-hemolytic streptococ-
ci (non-GAS) were more frequently found in 
school-aged children with special needs when 
compared to control group subjects, thus eliciting 
their increased susceptibility. All subjects carried 
β-hemolytic streptococci regardless of having 
had previous episodes of pharyngotonsillitis. It 
has been confirmed that individuals with Down 
syndrome and immunocompromised subjects 
deserve special attention as they are more sus-
ceptible to infectious diseases.
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